{"id":8117,"date":"2025-07-09T07:59:16","date_gmt":"2025-07-09T11:59:16","guid":{"rendered":"https:\/\/www.packagingindustrynews.com\/?p=8117"},"modified":"2025-07-09T07:59:16","modified_gmt":"2025-07-09T11:59:16","slug":"alvotech-expands-biosimilars-capabilities-with-ivers-lee-acquisition","status":"publish","type":"post","link":"https:\/\/www.packagingindustrynews.com\/?p=8117","title":{"rendered":"Alvotech expands biosimilars capabilities with Ivers-Lee acquisition"},"content":{"rendered":"


\n<\/p>\n

\n
\n
\n \n <\/picture>
Post-acquisition, Ivers-Lee will maintain its international customer base. Credit: Piotr Swat\/Shutterstock.<\/figcaption><\/figure>\n<\/p><\/div>\n

Alvotech, a global biotech company, has announced the acquisition of Ivers-Lee Group, a Switzerland-based provider of assembly and packaging services for the pharmaceutical sector.<\/p>\n

This strategic move is set to enhance Alvotech\u2019s capacity in the assembly and packaging of biosimilar medicines.<\/p>\n

Founded in 1947 in Burgdorf, Switzerland, Ivers-Lee has established itself as a provider of high-quality packaging services.<\/p>\n

With a good manufacturing practice-licensed and Food and Drug Administration-approved site in Burgdorf and a strategic business unit in L\u00f6rrach, Germany, Ivers-Lee\u2019s capabilities will be integrated into Alvotech\u2019s Technical Operations division.<\/p>\n

This integration will include the assembly and packaging of auto-injectors, prefilled syringes, safety devices, and vials.<\/p>\n

Ivers-Lee\u2019s managing director Peter Sch\u00fcpbach will continue in his role while also joining Alvotech\u2019s Technical Operations senior leadership team.<\/p>\n

Sch\u00fcpbach said: \u201cAlvotech offers the Ivers-Lee Group financial strength and development opportunities in a growth market, that we as a founding family cannot offer. This change brings stability both for Ivers-Lee and its employees.\u201d<\/p>\n

Post-deal, Ivers-Lee will maintain its international customer base and continue to offer contract manufacturing services, including blister and stick-pack activities, clinical supplies, and QP services from its L\u00f6rrach unit.<\/p>\n

The expansion of Alvotech\u2019s operations is poised to strengthen its position in the global pharmaceutical market.<\/p>\n

Alvotech founder, chair, and CEO Robert Wessman said: \u201cIvers-Lee has been an Alvotech preferred partner in assembly and packaging for several years. We know and trust each other very well, having worked closely together.<\/p>\n

\u201cAs Alvotech prepares for the launch of three new biosimilars in 2025 and sales growth in global markets, the integration of Ivers-Lee into our Technical Operations, provides added flexibility and capacity to meet increased global demand for our biosimilars, maintaining the highest level of quality and service.\u201d<\/p>\n

<\/p>\n

<\/p>\n

\n